SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TEBALDI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.313
AS - Asia 3.047
EU - Europa 1.648
SA - Sud America 500
Continente sconosciuto - Info sul continente non disponibili 175
AF - Africa 70
OC - Oceania 3
Totale 10.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.160
SG - Singapore 1.215
CN - Cina 683
BR - Brasile 390
DE - Germania 386
IT - Italia 359
VN - Vietnam 320
HK - Hong Kong 252
FI - Finlandia 214
GB - Regno Unito 137
BD - Bangladesh 135
FR - Francia 122
UA - Ucraina 104
TR - Turchia 101
CA - Canada 77
SE - Svezia 76
JP - Giappone 75
IN - India 74
RU - Federazione Russa 67
ID - Indonesia 57
PL - Polonia 53
MX - Messico 48
NL - Olanda 43
AR - Argentina 32
ZA - Sudafrica 31
IQ - Iraq 27
EC - Ecuador 25
CO - Colombia 17
ES - Italia 17
AT - Austria 14
PH - Filippine 13
LT - Lituania 12
VE - Venezuela 12
PK - Pakistan 11
BE - Belgio 10
MY - Malesia 10
KE - Kenya 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
JM - Giamaica 7
NP - Nepal 7
IE - Irlanda 6
MA - Marocco 6
PE - Perù 5
UY - Uruguay 5
CH - Svizzera 4
EG - Egitto 4
ET - Etiopia 4
IR - Iran 4
KR - Corea 4
KZ - Kazakistan 4
MD - Moldavia 4
PY - Paraguay 4
AU - Australia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
IL - Israele 3
KG - Kirghizistan 3
KW - Kuwait 3
NI - Nicaragua 3
SN - Senegal 3
TN - Tunisia 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
Totale 10.570
Salva come PNG Salva come JPEG
Città #
Ashburn 762
Singapore 713
San Jose 487
Fairfield 387
Woodbridge 311
Santa Clara 254
Munich 250
Hong Kong 248
Beijing 241
Houston 197
Chandler 174
Council Bluffs 147
Helsinki 139
Seattle 138
Wilmington 127
Cambridge 122
Ho Chi Minh City 114
Jacksonville 113
New York 109
Ann Arbor 105
Los Angeles 96
Dallas 91
Tokyo 75
Hanoi 65
Princeton 61
Lauterbourg 54
Milan 53
Jakarta 52
Izmir 51
Shanghai 50
San Diego 47
São Paulo 47
Warsaw 47
Nanjing 40
Ferrara 39
Turku 38
London 36
Chicago 32
Mexico City 29
Toronto 29
Brooklyn 27
Buffalo 25
Orem 25
Atlanta 24
Phoenix 24
Chennai 23
Bologna 19
Bremen 19
Denver 18
Frankfurt am Main 18
San Francisco 18
Boardman 17
Johannesburg 17
Stockholm 17
Boston 16
Haiphong 15
The Dalles 15
Montreal 14
Moscow 14
Rome 14
Tianjin 14
Nanchang 13
Nuremberg 13
Da Nang 12
Newark 12
Amsterdam 11
Augusta 11
Falls Church 11
Rio de Janeiro 11
Brussels 10
Charlotte 10
Dong Ket 9
Jyväskylä 9
Lappeenranta 9
Mumbai 9
Salt Lake City 9
Washington 9
Ankara 8
Brasília 8
Dhaka 8
Falkenstein 8
Jiaxing 8
Quito 8
Shenyang 8
Tashkent 8
Changsha 7
Goiânia 7
Hebei 7
Hefei 7
Hải Dương 7
Kathmandu 7
Nairobi 7
Ninh Bình 7
Norwalk 7
Baghdad 6
Bari 6
Campinas 6
City of London 6
Des Moines 6
Hangzhou 6
Totale 6.894
Salva come PNG Salva come JPEG
Nome #
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 437
Poor response to clopidogrel: current and future options for its management 314
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 301
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 292
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 253
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 243
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 242
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 236
Angina and left ventricular dysfunction: can we "reduce' it? 231
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 229
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 229
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 217
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 214
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 209
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 208
Fractional flow reserve: Current applications and overview of the available data 201
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 201
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 200
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 197
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 196
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 195
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 195
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 194
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 193
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 192
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 192
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) 191
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 190
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 186
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 184
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 177
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 177
Fractional flow reserve implementation in daily clinical practice: A European survey 176
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 176
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 175
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 171
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 168
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? 165
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 163
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 154
Enhanced stent visualization systems during PCI: A case series and review of literature 151
Seven french radial artery access for PCI: A prospective single-center experience 140
Functional Assessment and Acute Coronary Syndrome 137
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 131
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction 126
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 125
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 123
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 122
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. 121
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review 114
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 111
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 107
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial 102
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 96
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine 96
null 94
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 93
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study 93
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 86
Low FFR equal to low ischemia: Really? 66
The unbearable lightness of the instantaneous wave-free ratio/fractional flow reserve discordance 58
Totale 10.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.394
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022481 0 0 52 28 21 34 34 43 16 40 66 147
2022/2023471 59 23 36 27 74 62 25 49 66 6 32 12
2023/2024439 24 34 18 15 30 85 23 80 6 15 8 101
2024/20251.981 25 36 130 82 206 219 164 137 369 176 254 183
2025/20264.698 446 213 388 498 662 266 474 239 497 524 280 211
2026/2027507 140 220 147 0 0 0 0 0 0 0 0 0
Totale 10.756